Vyne Therap Rg

VYNE Therapeutics, a clinical‑stage biopharma in NJ, develops low‑systemic BET inhibitors for inflammatory disorders; lead products VYN201 (topical gel) and VYN202 (oral Phase 1b) target acne, rosacea, and other immune‑mediated diseases.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 13
HQ: Bridgewater

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
VYNE	Vyne Therap Rg Cap: 0.0B	EQUITY	NMS	USD	US92941V2097	Active	📈